The dangerous failure to stop tainted remdesivir
- During the pandemic’s deadly second wave, one firm’s substandard medication made many Indian patients sick
- Bihar’s regulator identified the cause. Their testing found Cadila’s batch V100167 to contain bacterial endotoxins which cause fever, chills and life-threatening septic shock.
BENGALURU : On 9 May 2021, at the height of the second covid wave in Uttar Pradesh, anesthesiologist Jitendra Pal got a call from the nursing staff at Jhansi’s Chiranjeev Hospital, where he is a consultant. The staff told him that two covid patients there had taken a turn for the worse after getting their first shots of the antiviral remdesivir. Within an hour of the injection, the patients began to shiver, their temperatures rose, and their blood oxygen levels (SPO2) dropped dramatically.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more